BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9721709)

  • 1. Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients.
    Bellantone R; Lombardi CP; Boscherini M; Ferrante A; Raffaelli M; Rubino F; Bossola M; Crucitti F
    J Surg Oncol; 1998 Aug; 68(4):237-41. PubMed ID: 9721709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment and long-term efficacy on stage T1-3N0 differentiated thyroid carcinoma].
    Li QL; Chen FJ; Zeng ZY; Guo ZM; Song M; Yang AK
    Ai Zheng; 2008 Mar; 27(3):299-303. PubMed ID: 18334121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
    Ebina A; Sugitani I; Fujimoto Y; Yamada K
    Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
    Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
    Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
    Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in differentiated carcinoma of the thyroid gland.
    Shah JP; Loree TR; Dharker D; Strong EW; Begg C; Vlamis V
    Am J Surg; 1992 Dec; 164(6):658-61. PubMed ID: 1463119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
    La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
    J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of lymph node metastases in follicular thyroid cancer.
    Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
    World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer.
    Kim WW; Park HY; Jung JH
    Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.
    Yin X; Liu C; Guo Y; Li X; Shen N; Zhao X; Yu P; Wang S; Liu Z
    World J Surg Oncol; 2017 Jul; 15(1):133. PubMed ID: 28716127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.
    Sabet A; Binse I; Dogan S; Koch A; Rosenbaum-Krumme SJ; Biersack HJ; Biermann K; Ezziddin S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):190-195. PubMed ID: 27530124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of patient and tumor related prognostic factors on survival in non-medullary differentiated thyroid cancer. A study of 125 cases].
    Dănilă R; Popovici R; Grigorovici A; Ionescu L; Timofte D; Lefter L; Boiculesei LV; Ungureanu MC; Dragomir C
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):940-5. PubMed ID: 18389784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.